Evidence map›Paper›PMID 39185426›Full record

ArticleFrontiers in immunology2024

Dietary galactose exacerbates autoimmune neuroinflammation

Stefanie Haase, Kristina Kuhbandner, Florian Mühleck, Barbara Gisevius, David Freudenstein, Sarah Hirschberg, De-Hyung Lee, Stefanie Kuerten, Ralf Gold, Aiden Haghikia and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefanie Haase *Department of Neurology, University Hospital Regensburg, Regensburg, Germany.
Kristina Kuhbandner *Department of Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Florian MühleckDepartment of Neurology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
Barbara GiseviusDepartment of Neurology, St. Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany.
David FreudensteinDepartment of Neurology, University Hospital Regensburg, Regensburg, Germany.
Sarah HirschbergDepartment of Neurology, St. Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany.
De-Hyung LeeDepartment of Neurology, University Hospital Regensburg, Regensburg, Germany.
Stefanie KuertenInstitute of Neuroanatomy, Faculty of Medicine, University of Bonn and University Hospital Bonn, Bonn, Germany.
Ralf GoldDepartment of Neurology, St. Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany.
Aiden HaghikiaDepartment of Neurology, University Medicine Magdeburg, Magdeburg, Germany.
Ralf A LinkerDepartment of Neurology, University Hospital Regensburg, Regensburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Recent studies provide increasing evidence for a relevant role of lifestyle factors including diet in the pathogenesis of neuroinflammatory diseases such as multiple sclerosis (MS). While the intake of saturated fatty acids and elevated salt worsen the disease outcome in the experimental model of MS by enhanced inflammatory but diminished regulatory immunological processes, sugars as additional prominent components in our daily diet have only scarcely been investigated so far. Apart from glucose and fructose, galactose is a common sugar in the so-called Western diet. Methods: We investigated the effect of a galactose-rich diet during neuroinflammation using myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE) as a model disease. We investigated peripheral immune reactions and inflammatory infiltration by Results: Young mice fed a galactose-rich diet displayed exacerbated disease symptoms in the acute phase of EAE as well as impaired recovery in the chronic phase. Galactose did not affect peripheral immune reactions or inflammatory infiltration into the CNS, but resulted in increased demyelination, oligodendrocyte loss and enhanced neuro-axonal damage Conclusion: These results imply that galactose-induced oligodendrocyte and myelin damage during neuroinflammation may be mediated by AGEs, thereby identifying galactose and its reactive products as potential dietary risk factors for neuroinflammatory diseases such as MS.

Indexed as

Encephalomyelitis, Autoimmune, ExperimentalGalactoseGlycation End Products, AdvancedMice, Inbred C57BLNeuroinflammatory DiseasesAnimalsDisease Models, AnimalFemaleMiceOligodendrogliaGalactoseGlycation End Products, Advancedadvanced glycation end productsgalactosehuman induced primary neuronsMOG-EAEmultiple sclerosisneuroinflammationoligodendrocytes

Identifiers

PMID39185426
PMCPMC11341352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.